Bridgebio Pharma, Inc. (BBIO) — DEFA14A Filings
All DEFA14A filings from Bridgebio Pharma, Inc.. Browse 1 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (1)
-
BridgeBio Pharma Files Proxy Materials
— May 9, 2025 Risk: low
BridgeBio Pharma, Inc. filed a Definitive Additional Materials (DEFA14A) on May 9, 2025. This filing is related to their proxy statement and does not involve a
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX